Funded Tech Companies
BioClin Therapeutics
Wondering who provided funding to BioClin Therapeutics? Tekla Capital Management, INKEF Capital and Healthcap Venture Capital joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
BioClin Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1040 Davis St. 202
San Leandro, CA 94577
USA
San Leandro, CA 94577
USA
Phone
Website
Email Address
Company Background Information
Overview
Our strategy is to develop biologics for medical conditions where there has been no approved or satisfactory therapy. Our lead product, B-701, is a human antibody targeting FGFR3 (fibroblast growth factor receptor 3) being developed as a treatment for metastatic bladder cancer and achondroplasia (dwarfism).
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/10/2018
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Stephen Lau
Chief Medical Officer
Steve Abella
Chief Operating Officer
Graeme Currie
VP - Finance
Guy Shields
VP - Manufacturing
Eric Emery
VP - Operations
Isagani Cornelio
Company Investors
- Tekla Capital Management
- INKEF Capital
- Healthcap Venture Capital
- Life Sciences Partners
- Sectoral Asset Management
- Sofinnova Ventures (David Kabakoff)
- Ysios Capital (Joël Jean-Mairet)
- Sofinnova Ventures (Cory Freedland)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs